Genesis 2026 - L04: Understand Investment Funds’ working dynamics

​We are pleased to welcome Annameta Gericke for our fourth session of Genesis 2026, dedicated to explore how investment funds evaluate and support emerging healthcare ventures. Annameta is a Venture Developer at NLC Health Ventures, focusing on identifying promising medical innovations and helping them transform into new companies. Her work brings together scientific discovery, venture creation, and early-stage investment in health technologies.

​In this session, she will provide an inside perspective on how investment funds assess opportunities, structure investments, and support the development of new companies. The participants will gain a clearer understanding of what investors look for in early-stage projects, how scientific ideas are evaluated in terms of their clinical and market potential, and how funding decisions shape the trajectory of development from research results to startups. This session will give a practical framework for researchers and entrepreneurs who want to understand better how to develop projects in translational innovation.